Search in:

Drug Design, Development and Therapy Volume 10, 2016 - Issue

Submit an article Journal homepage

Open access

141

Views

CrossRef citations to date

Altmetric

Review

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date

Yehenew A Ebstie1 Department of Microbiology, Immunology and ParasitologyCorrespondence[email protected]

Solomon M Abay2 Department of Pharmacology

Wondmagegn T Tadesse3 Department of Pharmacology and Clinical Pharmacy, School of Medicine, College of Health Sciences, Addis Ababa University

Dawit A Ejigu4 Department of Pharmacology, St Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia

Pages 2387-2399 | Published online: 26 Jul 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (31)

Théoneste Umumararungu, Jean Bosco Nkuranga, Gratien Habarurema, Jean Baptiste Nyandwi, Marie Jeanne Mukazayire, Janvier Mukiza, Raymond Muganga, Innocent Hahirwa, Matabishi Mpenda, Alain Nyirimigabo Katembezi, Emmanuel Oladayo Olawode, Egide Kayitare & Pierre Claver Kayumba. (2023) Recent developments in antimalarial drug discovery. Bioorganic & Medicinal Chemistry 88-89, pages 117339.
Crossref

Himani Tripathi, Preshita Bhalerao, Sujeet Singh, Hemant Arya, Bader Saud Alotaibi, Summya Rashid, Mohammad Raghibul Hasan & Tarun Kumar Bhatt. (2023) Malaria therapeutics: are we close enough?. Parasites & Vectors 16:1.
Crossref

Kabiruddin Khan, Supratik Kar & Kunal Roy. (2023) Are we ready to combat the ecotoxicity of COVID-19 pharmaceuticals? An in silico aquatic risk assessment. Aquatic Toxicology 256, pages 106416.
Crossref

Yogesh Kumar, Akanksha Jain & Ravindra Kumar. 2023. Natural Product Based Drug Discovery Against Human Parasites. Natural Product Based Drug Discovery Against Human Parasites 451 469 .

Astrid Lorena Cubillos, Alexandra Porras & Alejandro Rico. (2022) Eficacia de la tafenoquina en la profilaxis y tratamiento de la malaria por Plasmodium vivax, revisión sistemática y metaanálisis. Biomédica 42:2, pages 364-377.
Crossref

Nathália N. Chamma-SiqueiraSuiane C. NegreirosSarah-Blythe BallardSâmela FariasSandro P. SilvaStella M. ChenetEduardo J.M. SantosLuann W. Pereira de SenaFlávia Póvoa da CostaAmanda G.N. Cardoso-MelloPaola B. MarchesiniCássio R.L. PeterkaGiselle M.R. VianaAlexandre Macedo de Oliveira. (2022) Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria . New England Journal of Medicine 386:13, pages 1244-1253.
Crossref

Yeh Chen, Wen-Hao Yang, Hsiao-Fan Chen, Li-Min Huang, Jing-Yan Gao, Cheng-Wen Lin, Yu-Chuan Wang, Chia-Shin Yang, Yi-Liang Liu, Mei-Hui Hou, Chia-Ling Tsai, Yi-Zhen Chou, Bao-Yue Huang, Chian-Fang Hung, Yu-Lin Hung, Wei-Jan Wang, Wen-Chi Su, Vathan Kumar, Yu-Chieh Wu, Shih-Wei Chao, Chih-Shiang Chang, Jin-Shing Chen, Yu-Ping Chiang, Der-Yang Cho, Long-Bin Jeng, Chang-Hai Tsai & Mien-Chie Hung. (2022) Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2. Journal of Biological Chemistry 298:3, pages 101658.
Crossref

Mitali Mishra, Vikash Kumar Mishra, Varsha Kashaw & Sushil Kumar Kashaw. 2021. Plasmodium Species and Drug Resistance. Plasmodium Species and Drug Resistance.

Min Zhou, Ayşegül Varol & Thomas Efferth. (2021) Multi-omics approaches to improve malaria therapy. Pharmacological Research 167, pages 105570.
Crossref

Riti Mehta & Souvik Sengupta. 2021. Emerging Trends in Nanomedicine. Emerging Trends in Nanomedicine 203 234 .

Hafiz Muhammad Rizwan, Haider Abbas, Muhammad Sohail Sajid, Mahvish Maqbool, Malcolm K. Jones, Muhammad Irfan Ullah & Nabeel Ijaz. 2021. Biochemistry of Drug Resistance. Biochemistry of Drug Resistance 95 142 .

María Álvarez-Bardón, Yolanda Pérez-Pertejo, César Ordóñez, Daniel Sepúlveda-Crespo, Nestor M. Carballeira, Babu L. Tekwani, Sankaranarayanan Murugesan, Maria Martinez-Valladares, Carlos García-Estrada, Rosa M. Reguera & Rafael Balaña-Fouce. (2020) Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria. Marine Drugs 18:4, pages 187.
Crossref

Kuan-Yi Lu & Emily R. Derbyshire. (2020) Tafenoquine: A Step toward Malaria Elimination. Biochemistry 59:8, pages 911-920.
Crossref

Anas Najjar, Abderrahman Najjar & Rafik Karaman. (2020) Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years. Molecules 25:4, pages 884.
Crossref

Renan Vinicius de Araújo, Soraya Silva Santos, Luccas Missfeldt Sanches, Jeanine Giarolla, Omar El Seoud & Elizabeth Igne Ferreira. (2020) Malaria and tuberculosis as diseases of neglected populations: state of the art in chemotherapy and advances in the search for new drugs. Memórias do Instituto Oswaldo Cruz 115.
Crossref

Benedikt Ley, Ari Winasti Satyagraha, Hisni Rahmat, Michael E. von Fricken, Nicholas M. Douglas, Daniel A. Pfeffer, Fe Espino, Lorenz von Seidlein, Gisela Henriques, Nwe Nwe Oo, Didier Menard, Sunil Parikh, Germana Bancone, Amalia Karahalios & Ric N. Price. (2019) Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis. PLOS Medicine 16:12, pages e1002992.
Crossref

Edwin G. Tse, Marat Korsik & Matthew H. Todd. (2019) The past, present and future of anti-malarial medicines. Malaria Journal 18:1.
Crossref

Dana G Mordue & Gary P Wormser. (2019) Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection?. The Journal of Infectious Diseases 220:3, pages 442-447.
Crossref

Gokul Gopi, Surama Manjari Behera & Priyamadhaba Behera. (2019) Tafenoquine: A Breakthrough Drug for Radical Cure and Elimination of Malaria. Exploratory Research and Hypothesis in Medicine X:X, pages 1-6.
Crossref

P. Minodier & G. Noël. (2019) Quimioprofilaxis del paludismo. EMC - Pediatría 54:2, pages 1-8.
Crossref

Fabrizio Pertusati, Michaela Serpi & Elisa Pileggi. 2019. Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals. Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals 141 180 .

Patricia Schlagenhauf, Martin P. Grobusch, Davidson H. Hamer, Hilmir Asgeirsson, Mogens Jensenius, Gilles Eperon, Camilla Rothe, Egon Isenring, Jan Fehr, Eli Schwartz, Emmanuel Bottieau, Elizabeth D. Barnett, Anne McCarthy, Paul Kelly, Carsten Schade Larsen, Perry van Genderen, William Stauffer, Michael Libman & Philippe Gautret. (2018) Area of exposure and treatment challenges of malaria in Eritrean migrants: a GeoSentinel analysis. Malaria Journal 17:1.
Crossref

Gisela Henriques, Koukeo Phommasone, Rupam Tripura, Thomas J. Peto, Shristi Raut, Coco Snethlage, Im Sambo, Nou Sanann, Chea Nguon, Bipin Adhikari, Tiengkham Pongvongsa, Mallika Imwong, Lorenz von Seidlein, Nicholas P. Day, Nicholas J. White, Arjen M. Dondorp, Paul Newton, Benedikt Ley & Mayfong Mayxay. (2018) Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia. Malaria Journal 17:1.
Crossref

Henriette Bosson-Vanga, Jean-François Franetich, Valérie Soulard, Daniel Sossau, Maurel Tefit, Bocar Kane, Jean-Christophe Vaillant, Steffen Borrmann, Olaf Müller, Nathalie Dereuddre-Bosquet, Roger Le Grand, Olivier Silvie & Dominique Mazier. (2018) Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium. Malaria Journal 17:1.
Crossref

Mohammad Shafiul Alam, Mohammad Golam Kibria, Nusrat Jahan, Kamala Thriemer, Mohammad Sharif Hossain, Nicholas M. Douglas, Ching Swe Phru, Wasif Ali Khan, Ric N. Price & Benedikt Ley. (2018) Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity. PLOS ONE 13:11, pages e0206331.
Crossref

Rob Hooft van Huijsduijnen & Timothy NC Wells. (2018) The antimalarial pipeline. Current Opinion in Pharmacology 42, pages 1-6.
Crossref

James E. Frampton. (2018) Tafenoquine: First Global Approval. Drugs 78:14, pages 1517-1523.
Crossref

Navin Goyal, Khadeeja Mohamed, Katie Rolfe, Satty Sahota, Terry Ernest, Stephan Duparc, Maxine Taylor, Linda Casillas & Gavin C. K. W. Koh. (2018) Application of the Stable Isotope Label Approach in Clinical Development—Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound. The AAPS Journal 20:4.
Crossref

Anna Caroline C. Aguiar, Flávio Jr. B. Figueiredo, Patrícia D. Neuenfeldt, Tony H. Katsuragawa, Bruna B. Drawanz, Wilson Cunico, Photini Sinnis, Fidel Zavala & Antoniana U. Krettli. (2017) Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms. Malaria Journal 16:1.
Crossref

Johanna P. Daily. (2017) Malaria 2017: Update on the Clinical Literature and Management. Current Infectious Disease Reports 19:8.
Crossref

Anna Rivkin, Sharon Ben-Hur & Neta Regev-Rudzki. (2017) Malaria Parasites Distribute Subversive Messages across Enemy Lines. Trends in Parasitology 33:1, pages 2-4.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date

Articles from other publishers (31)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date

Citations (31)

Articles from other publishers (31)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date